Biofrontera (BFRI) Asset Writedowns and Impairment (2020 - 2025)
Biofrontera (BFRI) posted quarterly Asset Writedowns and Impairment of -$25000.0 for Q4 2025, down 149.02% year-over-year from $51000.0 in Q4 2024, and down 292.31% quarter-over-quarter from $13000.0 in Q3 2025.
Biofrontera (BFRI) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Biofrontera's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$25000.0 for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment fell 149.02% year-over-year to -$25000.0; the TTM figure through Dec 2025 stood at -$69000.0 (down 142.59% YoY), while the FY2025 annual figure was -$69000.0, down 142.59% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at -$25000.0, down from $13000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $94000.0 in Q3 2023, with the low at -$46000.0 in Q1 2025.
- The 5-year median for Asset Writedowns and Impairment is $12000.0 (2022), against an average of $17400.0.
- Peak annual rise in Asset Writedowns and Impairment reached 5900.0% in 2022, while the deepest fall reached 650.0% in 2022.
- Biofrontera's Asset Writedowns and Impairment stood at $2000.0 in 2021, then slumped by 650.0% to -$11000.0 in 2022, then sank by 227.27% to -$36000.0 in 2023, then soared by 241.67% to $51000.0 in 2024, then tumbled by 149.02% to -$25000.0 in 2025.
- Business Quant data shows BFRI's Asset Writedowns and Impairment at -$25000.0 in Q4 2025, $13000.0 in Q3 2025, and -$11000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Sep 30, 2023 | 94,000.00 |